Angelman Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
Condition:   Angelman Syndrome Intervention:   Drug: ION582 Sponsor:   Ionis Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 19, 2021 Category: Research Source Type: clinical trials

Angelman Syndrome Natural History Study- FAST UK
Condition:   Angelman Syndrome Intervention:   Other: Natural History Study Sponsors:   University of Oxford;   Foundation for Angelman Syndrome Therapeutics UK;   Hoffmann-La Roche Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 29, 2021 Category: Research Source Type: clinical trials